Revenues for the year to September 30 should exceed $190 million (£118 million) – well ahead of forecast
Retinal imaging firm Optos is reporting strong fourth quarter sales which it predicts will lift full-year turnover figures.
The Dunfermline-based company said full-year revenues for the year to September 30 should exceed $190 million (£118 million) – well ahead of forecast.
Operating profits for the year are also predicted to be “slightly above market consensus”.
The rise in revenues in the fourth quarter came largely from a reported $17 million (£10.8 million) worth of advanced orders for its Daytona desktop retinal imaging device, which the company said in July it expected to deliver by the financial year end.
In a trading update posted today, Optos said 329 of the Daytona devices had been installed by the year end.
The number of core fixed ultra-wide field products installed rose by 11 per cent in the year to 4,700.
Optos, which develops imaging technology for eye tests, posted a 77 per cent rise in pre-tax profits to £4.3 million for the first half to March 31 on a 47 per cent rise in turnover to £54 million.
Optos chief executive Roy Davis said: “I am delighted with the company's achievements this year and, in particular, the manufacturing scale-up and market roll-out of Daytona.
“The reaction to this instrument has been very positive and I am excited by the opportunities it brings to the business.
“Our near-term focus is to drive sales of Daytona in all our key markets and to continue our success with the 200Tx instrument in the ophthalmology market.”
Shares in Optos were up more than six per cent in early trading today.